This immune profile, influenced by host genetic variants such as FOXP3 and HLA‐G polymorphisms, fosters a tumor microenvironment that favors immune evasion, epithelial‐mesenchymal transition (EMT), and metastasis. The gene discussed is FOXP3; the disease is neoplasm.